Codon72 polymorphism in the p53 tumor suppressor gene in oral lichen planus lesions in a Thai population

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 4, 2010, Pages 1137-1141

  Yanatatsaneeji, Pattamawadee ^a   Kitkumthorn, Nakarin ^b   Dhammawipark, Chutintorn ^a   Rabalert, Jierada ^a   Patel, Vyomesh ^c   Mutirangura, Apiwat ^d  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^d CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Apoptosis; Oral lichen planus; p53 codon 72; Polymorphism

Indexed keywords

EID: 78650683136     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Acay RR, Felizzola CR, de Araujo N, et al (2006). Evaluation of proliferative potential in oral lichen planus and oral lichenoid lesions using immunohistochemical expression of p53 and Ki67. Oral Oncol, 42, 475-80.
2. Acharya M, Mitra S, Mukhopadhyay A, et al (2002). Distribution of p53 codon 72 polymorphism in Indian primary open angle glaucoma patients. Mol Vis, 8, 367-71.
3. Axell T and Rundquist L (1987). Oral lichen planus--a demographic study. Community Dent Oral Epidemiol, 15, 52-6.
4. Beckman G, Birgander R, Sjalander A, et al (1994). Is p53 polymorphism maintained by natural selection? Hum Hered, 44, 266-70.
5. Bonafe M, Salvioli S, Barbi C, et al (2002). p53 codon 72 genotype affects apoptosis by cytosine arabinoside in blood leukocytes. Biochem Biophys Res Commun, 299, 539-41.
6. Bouvard V, Zaitchouk T, Vacher M, et al (2000). Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice. Oncogene, 19, 649-60.
7. Brenna SM, Silva ID, Zeferino LC, et al (2004). Prognostic value of P53 codon 72 polymorphism in invasive cervical cancer in Brazil. Gynecol Oncol, 93, 374-80.
8. Dumont P, Leu JI, Della Pietra AC, et al (2003). The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet, 33, 357-65.
9. Ghabanchi J, Fattahi MJ, Mardani M, et al (2009). Polymorphism of tumor protein p53 codon 72 showed no association with oral lichen planus in shiraz, Iran. J Craniofac Surg, 20, 2168-70.
10. Gonzalez-Moles MA, Gil-Montoya JA, Ruiz-Avila I, et al (2008). Differences in the expression of p53 protein in oral lichen planus based on the use of monoclonal antibodies DO7 and pAb 240. Oral Oncol, 44, 496-503.
11. Guillermo LV, Silva EM, Ribeiro-Gomes FL, et al (2007). The Fas death pathway controls coordinated expansions of type 1 CD8 and type 2 CD4 T cells in Trypanosoma cruzi infection. J Leukoc Biol, 81, 942-51.
12. Jin X, Wu X, Roth JA, et al (1995). Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis, 16, 2205-8.
13. Kuroda Y, Nakao H, Ikemura K, et al (2007). Association between the TP53 codon72 polymorphism and oral cancer risk and prognosis. Oral Oncol, 43, 1043-8.
14. Lin HJ, Chen WC, Tsai FJ, et al (2002a). Distributions of p53 codon 72 polymorphism in primary open angle glaucoma. Br J Ophthalmol, 86, 767-70.
15. Lin P, Bush JA, Cheung KJ, et al (2002b). Tissue-specific regulation of Fas/APO-1/CD95 expression by p53. Int J Oncol, 21, 261-4.
16. Lopez-Jornet P, Camacho-Alonso F, Berdugo ML (2009). Measuring the impact of oral mucosa disease on quality of life. Eur J Dermatol, 19, 603-6.
17. Meulmeester E and Jochemsen AG (2008). p53: a guide to apoptosis. Curr Cancer Drug Targets, 8, 87-97.
18. Nayak SK, Panesar PS, Kumar H (2009). p53-Induced apoptosis and inhibitors of p53. Curr Med Chem, 16, 2627-40.
19. Neppelberg E, Johannessen AC, Jonsson R (2001). Apoptosis in oral lichen planus. Eur J Oral Sci, 109, 361-4.
20. Ngan HY, Liu VW, Liu SS (1999). Risk of cervical cancer is not increased in Chinese carrying homozygous arginine at codon 72 of p53. Br J Cancer, 80, 1828-9.
21. Ni X, Hazarika P, Zhang C, et al (2001). Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape? Clin Cancer Res, 7, 2682-92.
22. Peixoto Guimaraes D, Hsin Lu S, Snijders P, et al (2001). Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China. Cancer Lett, 162, 231-5.
23. Porter SR, Kirby A, Olsen I, et al (1997). Immunologic aspects of dermal and oral lichen planus: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 83, 358-66.
24. Schneider-Stock R, Mawrin C, Motsch C, et al (2004). Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer. Am J Pathol, 164, 1233-41.
25. Settheetham-Ishida W, Yuenyao P, Tassaneeyakul W, et al (2006). Selected risk factors, human papillomavirus infection and the p53 codon 72 polymorphism in patients with squamous intraepithelial lesions in northeastern Thailand. Asian Pac J Cancer Prev, 7, 113-8.
26. Shen LJ, Ruan P, Xie FF (2004). Expressions of Fas/FasL and granzyme B in oral lichen planus and their significance. Di Yi Jun Yi Da Xue Xue Bao, 24, 1362-6.
27. Silva RE, Arruda JT, Rodrigues FW (2009). Primary open angle glaucoma was not found to be associated with p53 codon 72 polymorphism in a Brazilian cohort. Genet Mol Res, 8, 268-72.
28. Tanda N, Mori S, Saito K, et al (2000). Expression of apoptotic signaling proteins in leukoplakia and oral lichen planus: quantitative and topographical studies. J Oral Pathol Med 29, 385-93.
29. Tiwawech D, Srivatanakul P, Karaluk A, et all (2003). The p53 codon 72 polymorphism in Thai nasopharyngeal carcinoma. Cancer Lett, 198, 69-75.
30. Tobon-Arroyave SI, Villegas-Acosta FA, Ruiz-Restrepo SM, et al (2004). Expression of caspase-3 and structural changes associated with apoptotic cell death of keratinocytes in oral lichen planus. Oral Dis, 10, 173-8.
31. Vousden KH (2005). Apoptosis. p53 and PUMA: a deadly duo. Science, 309, 1685-6.
32. Weston A, Perrin LS, Forrester K, et al (1992). Allelic frequency of a p53 polymorphism in human lung cancer. Cancer Epidemiol Biomarkers Prev, 1, 481-3.
33. Yonish-Rouach E, Resnitzky D, Lotem J, et al (1991). Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature, 352, 345-7.
34. Zuckerman V, Wolyniec K, Sionov RV, et al (2009). Tumour suppression by p53: the importance of apoptosis and cellular senescence. J Pathol, 219, 3-15.